What is a CA 19-9 test?
CA 19-9 (cancer antigen 19-9) is a protein marker measured in the blood in units per millilitre (U/mL). It is the marker most closely linked with pancreatic cancer, and it is also used in cancers of the bile ducts and gallbladder.
Its role is narrow and specific: doctors use CA 19-9 to monitor a known pancreatic or biliary cancer (is treatment working, is it coming back), not to screen healthy people. Used as a general “cancer check”, it produces far more false alarms than useful findings, because several benign conditions raise it too.
CA 19-9 normal range
| Result | Typical range | Interpretation |
|---|---|---|
| Normal | Below 37 U/mL | Usual cutoff in most labs |
| Mildly raised | 37–100 U/mL | Often benign biliary causes |
| Markedly raised | Above 100 U/mL | Needs investigation in context |
| Lewis negative people | Very low / undetectable | Marker not usable in 5–10% of people |
Cutoffs differ slightly between laboratories, so always read your value against the range printed on your own report.
What a high CA 19-9 can mean (and what it can’t)
A raised CA 19-9 is most meaningful when pancreatic or biliary cancer is already diagnosed: there, a falling level suggests treatment is working and a rising level after treatment can be the first hint of recurrence. That monitoring role is where the test earns its place.
Outside that setting, benign causes dominate. Blockage of the bile duct, whether from gallstones, strictures, or inflammation, is the classic benign cause; the marker often normalises once bile flow is restored. Acute or chronic pancreatitis, liver cirrhosis, and other gastrointestinal conditions can also raise it. This is why a raised CA 19-9 in someone without known cancer leads to scans and clinical review, not to a cancer diagnosis.
There is also an important caveat in the other direction: roughly 5–10% of people are Lewis antigen negative and cannot make CA 19-9 at all. In these individuals the test stays low regardless of disease, so a “normal” CA 19-9 reassures no one and doctors simply use other tools.
CA 19-9 vs other tumour markers
| Marker | Most linked with | Main use | Key limitation |
|---|---|---|---|
| CA 19-9 | Pancreatic cancer | Monitoring pancreatic and biliary cancers | Rises in bile duct blockage; useless in Lewis-negative people |
| CEA | Colorectal cancer | Monitoring treatment and recurrence | Rises with smoking and liver disease |
| AFP | Liver cancer, germ cell tumours | Liver cancer surveillance; pregnancy screening | Rises in hepatitis and pregnancy |
| CA-125 | Ovarian cancer | Monitoring ovarian cancer | Rises in endometriosis and menstruation |
| PSA | Prostate cancer | Prostate screening and monitoring | Rises in benign prostate enlargement |
Each marker is tied to particular cancers and particular jobs; none works as a general cancer screen.
Reading your report: what your doctor actually looks at
- Is there known pancreatic or biliary disease? The marker is most meaningful as a monitoring tool in diagnosed disease.
- Is there jaundice or bile duct blockage? Cholestasis alone can push CA 19-9 well above the cutoff; doctors recheck after the blockage clears.
- How high is it? Mild elevations most often reflect benign biliary or pancreatic irritation; markedly high values deserve fuller investigation.
- What is the trend? In monitored patients, the direction of travel across repeat tests carries the real information.
- Could you be Lewis negative? If the clinical picture is concerning but CA 19-9 stays flat, this caveat is worth discussing.
A mildly raised CA 19-9 with gallstones or pancreatitis is a common, explainable finding. Discuss the whole picture with your doctor before drawing conclusions.
CA 19-9 test price in India
CA 19-9 is a specialised immunoassay and typically falls in the ₹1,000–₹2,000 band in India, though prices vary by city and lab. Home collection can add a small fee.
Because the test is most useful tracked over time, repeat tests are best done at the same laboratory: different analysers can read slightly differently and fake a trend. Where possible, choose a NABL-accredited lab.
Questions to ask your doctor
- Why was CA 19-9 ordered: monitoring known disease, or investigating a raised value?
- Could bile duct blockage or pancreatitis explain my result?
- When should we repeat it, and should it be at the same lab?
- What imaging or referral comes next if it stays raised?
Frequently Asked Questions
What is the full form of CA 19-9?
CA 19-9 stands for cancer antigen 19-9 (also called carbohydrate antigen 19-9). It is a protein marker most closely associated with pancreatic and biliary cancers.
Do I need to fast for a CA 19-9 test?
No. The CA 19-9 test does not require fasting and can be taken at any time of day.
Can CA 19-9 be high without cancer?
Yes, quite often. Bile duct blockage (cholestasis), pancreatitis, liver cirrhosis, and other benign biliary conditions commonly raise CA 19-9. A raised value prompts investigation, usually imaging, rather than giving a diagnosis by itself.
I have jaundice. Will it affect my CA 19-9?
Yes. Jaundice from a blocked bile duct is one of the commonest benign reasons for a high CA 19-9. Doctors usually recheck the marker after the blockage is relieved, since the level often falls back once bile flows normally again.
What does it mean if I am Lewis antigen negative?
About 5–10% of people are Lewis antigen negative and produce little or no CA 19-9, so the test can read low or “normal” even when disease is present. In these people the marker is simply not useful, and doctors rely on imaging and other tests instead.
How much does the CA 19-9 test cost in India?
The CA 19-9 test typically costs in the ₹1,000–₹2,000 band in India, though prices vary by city and lab. Choose a NABL-accredited lab where possible, and remember the reference range printed on your own report is the one that counts.
Pharmacist's practical notes
The first question with any CA 19-9 result is whether there is a biliary explanation. Gallstones and bile duct strictures are common, they push this marker up reliably, and the level usually settles once bile flows again. A raised CA 19-9 plus jaundice is a plumbing problem until proven otherwise, so do not leap past that step.
Do not use CA 19-9 as a self-ordered “pancreatic cancer screen”. In healthy people it is wrong far more often than it is right, and the anxiety and scans that follow a false alarm are real harms. Proper concern about pancreatic cancer is a conversation with your doctor about symptoms, family history, and appropriate imaging, not a single blood marker.
If you are being monitored with CA 19-9, insist on the same laboratory for every repeat. Assay differences between manufacturers are large enough to mimic a rise or fall, and treatment decisions should never rest on numbers from two different machines. Keep your old reports together so trends are easy to see.
Ask about the Lewis antigen caveat if your clinical picture is worrying but CA 19-9 stays stubbornly normal. Around one person in ten to twenty cannot produce this marker, and knowing that changes how much weight anyone should give the result. If a result surprises you, discuss it with your doctor before repeating the test.
In India
Indian labs report CA 19-9 in U/mL, the same unit used internationally, so the ranges on this page apply directly. Gallstone disease is common in India, which makes benign biliary elevation of CA 19-9 a frequent and usually explainable finding; the typical price band is ₹1,000–₹2,000, varying by city and lab.
Where possible, choose a NABL-accredited lab. Reference ranges can differ slightly depending on the analyser a lab uses, so the range printed on your own report is the one that counts, not a number from a website. Discuss the result with your doctor rather than interpreting it alone.
References
Sources cited on this page.
- StatPearls: Cancer Antigen 19-9 (CA 19-9). NCBI Bookshelf, peer-reviewed clinical summary.
- American Cancer Society: Tumor Markers. Patient guide to how tumour markers are used.
- National Cancer Institute: NCI Dictionary of Cancer Terms, entry for CA 19-9.